Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders / Joanne J. Liu en The Journal of Clinical Psychiatry, Año 2013 - Vol.74 - No.7 (Julio)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.7 (Julio) . - pp. 732-738 Título : Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders Tipo de documento: texto impreso Autores: Joanne J. Liu, Autor ; Hanga C. Galfalvy, Autor ; Thomas B. Cooper, Autor Fecha de publicación: 2022 Artículo en la página: pp. 732-738 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos de ansiedad, Trastorno depresivo mayor, Ácidos grasos Omega-3, Pruebas psicológicas. Resumen: Although lower levels of omega-3 polyunsaturated fatty acids (PUFAs) are found in major depressive disorder, less is known about PUFA status and anxiety disorders. Link: ./index.php?lvl=notice_display&id=27872 [artículo] Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders [texto impreso] / Joanne J. Liu, Autor ; Hanga C. Galfalvy, Autor ; Thomas B. Cooper, Autor . - 2022 . - pp. 732-738. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.7 (Julio) . - pp. 732-738 Palabras clave: Trastornos de ansiedad, Trastorno depresivo mayor, Ácidos grasos Omega-3, Pruebas psicológicas. Resumen: Although lower levels of omega-3 polyunsaturated fatty acids (PUFAs) are found in major depressive disorder, less is known about PUFA status and anxiety disorders. Link: ./index.php?lvl=notice_display&id=27872

Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder / Barbara Geller en Annual progress in child psychiatry and child develoment, Año 1993 ([09/11/2020])

Público ISBD [artículo]  inAnnual progress in child psychiatry and child develoment > Año 1993 [09/11/2020] . - pp. 477-502 Título : Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder Tipo de documento: texto impreso Autores: Barbara Geller, Autor ; Thomas B. Cooper, Autor ; Donna L. Graham, Autor Fecha de publicación: 2020 Artículo en la página: pp. 477-502 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo, Nortriptilina, Evaluación de personalidad Resumen: A random assignment, double-blind, placebo-controlled study of nortriptyline in 50 prepubertal 6- to 12-year-olds with Research Diagnostic Criteria and DSM-III major depressive disorder was performed. The protocol included a 2-week placebo wash-out phase and an 8-week double-blind, placebo-controlled phase with weekly plasma level monitoring. Link: ./index.php?lvl=notice_display&id=25170 [artículo] Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder [texto impreso] / Barbara Geller, Autor ; Thomas B. Cooper, Autor ; Donna L. Graham, Autor . - 2020 . - pp. 477-502. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Annual progress in child psychiatry and child develoment > Año 1993 [09/11/2020] . - pp. 477-502 Palabras clave: Trastorno depresivo, Nortriptilina, Evaluación de personalidad Resumen: A random assignment, double-blind, placebo-controlled study of nortriptyline in 50 prepubertal 6- to 12-year-olds with Research Diagnostic Criteria and DSM-III major depressive disorder was performed. The protocol included a 2-week placebo wash-out phase and an 8-week double-blind, placebo-controlled phase with weekly plasma level monitoring. Link: ./index.php?lvl=notice_display&id=25170

---

1 (1 - 2 / 2)